|
|
|
Balan News & Press Releases
|
|
|
| St. Jude Medical, Inc. Renews Development Contract with Balan Biomedical, Inc. - Thursday, December 18, 2008Dr. Elisabeth Hager, Chairman and CEO of Balan Biomedical, Inc. announced that St. Jude Medical, Inc (SJM) renewed its contract for a range of engineering services from Balan. The members of Balan’s Engineering Division support the internal R & D projects of SJM, allowing optimization of resources while providing cost effective expertise.
“Our relationship with SJM has grown over the years and we enjoy working collaboratively on key projects with the SJM staff as we work to make our client as competitive as possible in this global marketplace” explains Michael Pyszczek, VP of Technology. “The continued growth of the Balan Engineering Division is reflected in our recent staff expansion which allows us to offer even greater value to our clients.”
|
|
| Balan Biomedical, Inc. Announces the formation of Battery Consulting Group - Monday, October 27, 2008Mr. Michael Pyszczek to lead broad-based team of battery experts.
Dr. Elisabeth Hager, Chairman and CEO of Balan Biomedical, Inc. announced the formation of the Balan Biomedical Battery Consulting Group. The newly created consulting group, reporting to Balan’s Engineering Division, will be led by Mr. Michael Pyszczek, Balan’s V.P. of Technology. Joining Mr. Pyszczek will be Dr. Christopher R. Feger (Biomedical Systems and Materials) and Dr. Kenneth C. Syracuse (Statistical Analytics and Mathematical Modeling). The group will operate out of Balan’s USA Headquarters located in Rochester, New York.
Balan’s team members have a combined 65 years of experience in the battery industry with expertise covering a broad spectrum of technology, from high-performance commercial batteries to high-reliability batteries for implantable medical devices. Services will include Battery Application Review, Educational Training, Technology Assessment, Patent Searching and Analysis, Quality Systems Review and Development, Materials Sourcing, Manufacturing Process Review, Safety & Performance Assessment, Data Analysis, and Documentation Support (ISO, GMP, and FDA).
“We’ve been working on a number of battery related projects over the last few years and have helped our customers; battery manufacturers, OEMs, and end-users; solve their power source problems,” explains Dr. Hager. “Our team has successfully provided help with overseas manufacturing, data analysis, safety and handling practices, and performance issues. We’ve identified, through our work on these projects, a need within the industry for a broad-based Battery Consulting Group and we’re pleased to be able to offer our expertise in this area.”
|
|
| Balan Biomedical Announces the Launch of Their Newly Redesigned Web Site - Friday, September 19, 2008Understanding the importance of conveying a clear and concise message to its existing and potential clients Balan Biomedical announces the launch of its redesigned website. Not only does the new site convey a fuller understanding of Balan’s capabilities and services, many enhancements were made to ease of navigation and performance. “As a Biomedical Intelligence company we understand how important it is for a visitor to easily get the information they need from our website. We’ve made this redesign an integral part of our operational improvements,” said Elisabeth Hager, Chairman and CEO of Balan Biomedical.
Balan expects to continue to make improvements to their website both on the business side and in its extensive collection of Medical Professional Network pages tailored specifically for members. ##
|
|
| Balan Biomedical adds Dr. Christopher Feger Ph.D. to its team. - Monday, September 01, 2008Balan Biomedical announced today the addition of Dr. Christopher Feger Ph.D. to its team. Chris Feger earned his degrees in chemistry from MIT and Ohio State University. Dr. Feger previously served as Principal Scientist at St. Jude Medical involving various projects where he utilized his expertise in project management, and process and quality system development. He has published several papers in the field of solid state materials and has been awarded eleven patents. ##
|
|
| Chairman and CEO Elisabeth Hager Interviewed for Sky Radio - Monday, August 18, 2008
On August 13th Balan Chairman and CEO Elisabeth Hager, M.D. was invited to the Los Angles studios of Sky Radio in order to be interviewed as part of their 21st Century Healthcare Forum. The Sky Radio Network provides business, technology, health and entertainment programming to some of the largest airlines in the world, including United, American, Delta, Northwest, US Airways and America West. The mission of the Sky Radio Network is to produce high-quality business and technology programming which educates, informs and entertains airline passengers. Sky Radio is proud to deliver unparalleled programming, which addresses the needs and interests of the Executive Business Traveler and contributes to making each passenger’s flight an enriching experience.
The interview with Dr. Hager will be run during the month of November, 2008. ##
Play Interview
|
|
| Balan Biomedical Selects Collexis’ Mediator to Support Research in the Field of Biotechnology - Tuesday, August 05, 2008
Medical and Consumer Health Intelligence Company Implements Collexis’ Knowledge Discovery Technology as Tool to Facilitate Research and Trend Analysis
COLUMBIA, S.C. – (July 28, 2008) – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that it has contracted with Balan Biomedical, Inc., a medical and consumer health intelligence company, to provide its Collexis Mediator product for the organization to support market research and trend analysis in the field of biotechnology. Balan will use the software as a research and analysis tool to identify and track clinical needs, which will facilitate consumer health research and clinical analytics.
Collexis Mediator offers researchers a more meaningful and efficient means of finding information by operating as an advanced text-mining tool and enables the end user to track scientific trends as well as conduct in-depth assessment of a given field of scientific investigation. Along with advanced document search and semantic analysis capabilities, Collexis Mediator is linked to a biomedical-expertise repository of over one million scientists, the profiles of each expert being based on scientific articles published in peer-reviewed journals.
“We are pleased that Balan has chosen Collexis to support its market research and consulting in the field of biotechnology,” said Jon Lieberman, general manager, government and enterprise worldwide for Collexis. “This is an example of how Collexis’ technology can be used for more than academic research and fundamental research and discovery, but also for commercial use. The software allows an analyst to scour the market and pinpoint and monitor competition, as well as uncover targets for acquisition. We are excited about this announcement and hope this is the beginning of a lasting partnership.”
Balan Biomedical is working with Collexis developers to create its own analytic algorithm to conduct trend analysis based on data that is compiled through the software. By identifying areas of clinical interest, tracking clinical needs and trending what is happening with biomedical literature, Balan mitigates risk and leads to dramatic improvements in patient health through its innovative method that combines clinical needs forecasting, technology scouting, resource discovery and market assessment and evaluation.
Chief Executive Officer of Balan Biomedical Elisabeth Hager remarked, “We chose Collexis after conducting lots of research; we thought about building our own (text-mining tool), but were excited to learn that one with such impressive technology was already built. Collexis supports our business model nicely and we are very impressed with the level and quality of work—I anticipate Balan will incorporate more Collexis technology and products to support our market research and analytics in the future.” ##
|
|
|
|
|
|